ArticleJournal of thoracic disease2025
Efficacy and safety of combined Baduanjin-auricular acupressure treatment for the postoperative rehabilitation of patients with non-small cell lung cancer: protocol for a randomized controlled trial.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Active participation in postoperative pulmonary rehabilitation training is an indispensable part of the rehabilitation process for patients with lung cancer and is critical to improving the quality of life (QOL). Baduanjin or auricular acupuncture can significantly improve exercise tolerance, fatigue, and QOL in patients with lung cancer. Baduanjin promotes physical function and psychological well-being through gentle movement and breathing control, while auricular acupressure may further alleviate symptoms by modulating neuroendocrine pathways. Their integration could address multidimensional impairments (physical, emotional, and symptom-related) more comprehensively than either intervention alone. Current rehabilitation programs often lack accessible, low-cost adjunct therapies. The combination offers a feasible, patient-centered approach-Baduanjin provides structured exercise, and auricular acupressure requires minimal resources, making it suitable for home-based care. However, there is a paucity of research addressing the joint effects of the combined intervention of Baduanjin and auricular acupressure. Therefore, in this study, we aim to assess the efficacy of the combined intervention of Baduanjin and auricular acupressure as an alternative regimen for postoperative rehabilitation in patients with lung cancer. Methods: This four-arm parallel randomized controlled trial will randomize 236 lung cancer surgery patients (1:1:1:1) to: (I) Baduanjin plus auricular acupressure (BG + AAG), (II) Baduanjin group (BG), (III) auricular acupressure group (AAG), or (IV) control group (CG). Primary outcomes [6-minute walk distance (6MWD), cancer-related fatigue scale, and QOL core scale] will be assessed at baseline, 4 and 12 weeks by blinded evaluators. Secondary analysis of 6MWD at 6 months will compare BG + AAG versus CG. Treatment effects will be analyzed using repeated-measures ANOVA with intention-to-treat principle. Discussion: The four-arm, randomized controlled trial design of the study can enhance both the scientific rigor and reliability of the experiment. Its application can provide clear results and generalizable conclusions for researchers and thus help form a theoretical basis for developing alternative traditional Chinese medicine (TCM) therapy for the postoperative rehabilitation of patients with lung cancer. Trial Registration: China Clinical Trial Registry (No. ChiCTR2400085060, 30 May 2024).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.